Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
are seeking a highly motivated candidate to work on peptide-membrane interactions and the development of lipid nanoparticles (LNPs) for applications in both cancer therapy and the treatment of bacterial
-
/software-engineering/), which has a strong track record in model-based software development and undertakes research on applications in areas such as healthcare, cloud technology and internet-of-things
-
Fennoscandia—including infrastructure connected to resource extraction, military activities, and regional development—interacts with older roads, seasonal pathways, and Indigenous and local mobility systems
-
Researcher (R1) Positions PhD Positions Application Deadline 30 Sep 2026 - 23:59 (Europe/Brussels) Country Norway Type of Contract Temporary Job Status Full-time Offer Starting Date 1 Dec 2026 Is the job
-
Researcher (R1) Positions PhD Positions Application Deadline 30 Sep 2026 - 23:59 (Europe/Brussels) Country Norway Type of Contract Temporary Job Status Full-time Offer Starting Date 1 Dec 2026 Is the job
-
English English requirements for applicants from outside of EU/ EEA countries and exemptions from the requirements: https://www.mn.uio.no/english/research/phd/regulations/regulations.html#toc8 Grade
-
for applicants from outside of EU/ EEA countries and exemptions from the requirements: https://www.mn.uio.no/english/research/phd/regulations/regulations.html#toc8 Grade requirements: The norm is as follows
-
candidate to work on peptide-membrane interactions and the development of lipid nanoparticles (LNPs) for applications in both cancer therapy and the treatment of bacterial infections. The work will be
-
project description to be attached to the application for admission to the doctoral program. For more information, please see our website https://www.med.uio.no/english/research/phd/index.html Starting date
-
candidate to work on peptide-membrane interactions and the development of lipid nanoparticles (LNPs) for applications in both cancer therapy and the treatment of bacterial infections. The work will be